Markets

Palisade Bio To Present Four Presentations At United European Gastroenterology Week 2026 For Its PALI-2018 Program

Sep 28, 2026 · 08:53 AM ET· updated 1h ago

Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade" or the "Company"), a clinical-stage biopharmaceutical company developing next-generation prodrugs for patients living with inflammatory and fibrotic diseases,

Why It Matters

Palisade Bio will show their medicine research at a big conference next year. When a company presents science, it means they are moving forward with their work.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

PALI1.45

-0.00 (-0.34%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.